Faruqi & Faruqi, LLP is Investigating Intersect ENT, Inc. (XENT) on Behalf of its Shareholders

NEW YORK, June 18, 2018 /PRNewswire/ — Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential breaches of fiduciary duty by the board of directors at Intersect ENT, Inc. (“Intersect” or the “Company”) (NASDAQ: XENT).

Faruqi & Faruqi, LLP. (PRNewsfoto/Faruqi & Faruqi, LLP)

Request more information now by clicking here:  www.faruqilaw.com/XENT. There is no cost or obligation to you.

Take Action

If you currently own Intersect stock and would like to discuss your legal rights, please visit www.faruqilaw.com/XENT.  You can also contact us by calling Nina Varindani at (212) 983-9330 or by sending an e-mail to nvarindani@faruqilaw.com.  Faruqi & Faruqi, LLP also encourages anyone with information regarding Intersect’s conduct to contact the firm, including whistleblowers, former employees, shareholders and others.

Attorney Advertising.  The law firm responsible for this advertisement is Faruqi & Faruqi, LLP (www.faruqilaw.com).  Prior results do not guarantee or predict a similar outcome with respect to any future matter.  We welcome the opportunity to discuss your particular case.  All communications will be treated in a confidential manner.

Nina M. Varindani
685 Third Avenue, 26th Floor
New York, NY 10017
Telephone: (212) 983-9330

Cision View original content with multimedia:http://www.prnewswire.com/news-releases/faruqi–faruqi-llp-is-investigating-intersect-ent-inc-xent-on-behalf-of-its-shareholders-300667828.html

SOURCE Faruqi & Faruqi, LLP